Brenton K. McCright, PhD U.S. FDA

Dr. Brent McCright received his BS degree in electrical engineering from the University of Maryland and his PhD degree in molecular biology from the University of Utah. The focus of his thesis work was the identification and characterization of novel PP2A regulatory subunits that are involved in controlling cell proliferation. Dr. McCright then studied developmental biology and mammalian genetics during a post-doctoral fellowship research at The Jackson Laboratory. Dr. McCright joined the Division of Cellular and Gene Therapies, in the Office of Cellular, Tissue, and Gene Therapies, at the Center for Biologics Evaluation and Research of the FDA as a Principle Investigator in 2002. Dr. McCright’s lab investigates the function of key signaling molecules during organogenesis and tissue repair using a variety of methods, including MRI. The main goal of Dr McCright’s current research is to identify methods that can be used to predict the safety and effectiveness of cellular therapies. Dr. McCright is also a Product/CMC reviewer for cellular therapy INDs, BLAs, and works on policy development for cellular therapies.